| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,041 | 16,291 | 23,531 | 25,404 | | Cost of Revenue | 14,183 | 9,410 | 18,559 | 33,592 | | | Gross Profit | 6,858 | 6,881 | 4,972 | (8,188) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,205 | 9,754 | 10,551 | 7,472 | | Non Recurring | 1,220 | 1,810 |
-
| 1,570 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,567) | (4,683) | (5,579) | (17,230) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 31 | 60 | 103 | 262 | | Earnings Before Interest And Taxes | (4,536) | (4,623) | (5,476) | (16,968) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (4,536) | (4,623) | (5,476) | (16,968) | | Income Tax Expense | 26 | 212 | 239 | (48) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,562) | (4,835) | (5,715) | (16,920) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,562) | (4,835) | (5,715) | (16,920) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,562) | ($4,835) | ($5,715) | ($16,920) |
|
0.02% Nasdaq 0.00%
Income Statement
